North Macedonia vs Philippines: Pneumococcal conjugate second or third-dose vaccines (PCVc)
North Macedonia
60.0%
in 2025
Philippines
59.0%
in 2025
North Macedonia rank
145th
Philippines rank
146th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- North Macedonia
- Philippines
How they compare
North Macedonia currently reports 60.0% against 59.0% in Philippines, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Philippines ahead.
North Macedonia ranks 145th and Philippines ranks 146th of 192 countries.
Philippines has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | North Macedonia | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 24.3% | 24.3% | Philippines |
| 2020s | 54.5% | 70.2% | 15.7% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), North Macedonia or Philippines?
- North Macedonia, at 60.0% against 59.0% in Philippines as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between North Macedonia and Philippines?
- 1.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Philippines?
- 18 years are reported by both, from 2008 to 2025.
- How do North Macedonia and Philippines rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- North Macedonia ranks 145th and Philippines ranks 146th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.